Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04458064
Other study ID # ASUH1421/18
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date July 1, 2020

Study information

Verified date July 2020
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study targets to compare insertion facility, effect on hemodynamic parameters and effective ventilation using i-gel versus Air-Q LMA for pediatric patients undergoing short-duration surgical procedures.


Description:

The patient were divided into 2 groups. I gel group and Air Q group according to LMA type used to maintain airway ventilation.

The patients were compared according to insertion facility, effect on hemodynamic parameters and effective ventilation.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date July 1, 2020
Est. primary completion date July 1, 2020
Accepts healthy volunteers No
Gender All
Age group 3 Years to 10 Years
Eligibility Inclusion Criteria:

- ASA grade I-II

- operative time of =60 minutes

Exclusion Criteria:

- age >10 years

- ASA grade =II

- current or recently resolved upper respiratory tract infection

- presence of oropharynx or laryngeal pathologies or congenital anomalies

- pathologies inducing reflux or increasing the possibility of aspiration

- allergy to anaesthetic or drugs to be used, renal, cardiac or hepatic diseases, or bronchial asthma

Study Design


Related Conditions & MeSH terms

  • Easy Insertion, Complications Ans Suitability of i Gel and Air Q LMA

Intervention

Other:
LMA i gel
insertion of LMA for maintaining airway during anesthesia

Locations

Country Name City State
Egypt Ain Shams University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Supraglottic device success rate Fitness of LMA for ventilation 60 minutes